Showing results (151-160 of 175) with videos related to
Sort By:
Pageof 18
BJU International|June 3, 2015
Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trialJose A Karam, Catherine E Devine, Bryan M Fellman, et al.Genomics, Proteomics & Bioinformatics|July 5, 2021
Mako: A Graph-based Pattern Growth Approach to Detect Complex Structural VariantsJiadong Lin, Xiaofei Yang, Walter Kosters, et al.Genome Research|April 5, 2011
Natural genetic variation caused by small insertions and deletions in the human genomeRyan E Mills, W Stephen Pittard, Julienne M Mullaney, et al.Journal of Medicinal Chemistry|October 23, 1998
Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferaseD J Augeri, S J O'Connor, D Janowick, et al.Annals of Neurology|September 19, 2015
Epilepsy in adults with mitochondrial disease: A cohort studyRoger G Whittaker, Helen E Devine, Grainne S Gorman, et al.Journal of Gastrointestinal Oncology|January 5, 2018
Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonographyNaruhiko Ikoma, Jeffrey H Lee, Manoop S Bhutani, et al.Cancers|January 27, 2021
Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy ResponseAhmed A Abdelhakeem, Xuemei Wang, Rebecca E Waters, et al.Applied and Environmental Microbiology|March 27, 2026
Identification of a highly expressed gene cluster likely coding for benzene activation enzymes in a methanogenic enrichment cultureCourtney R A Toth, Olivia Molenda, Camilla L Nesbø, et al.European Urology Oncology|July 6, 2019
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II TrialNizar M Tannir, Pavlos Msaouel, Jeremy A Ross, et al.Journal of Gastrointestinal Oncology|August 27, 2016
Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experienceHumaid O Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, et al.Pageof 18